![Geoffrey Lynn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey Lynn
Plus aucun poste en cours
Fortune : 446 525 $ au 31/08/2026
Profil
Geoffrey Lynn is the founder of Avidea Technologies, Inc. Dr. Lynn was Chief Scientific Officer at Barinthus Biotherapeutics Plc from 2024 to 2025.
Dr. Lynn earned doctorates from the University of Oxford and The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 640 639 ( 1,63 % ) | 446 525 $ | 31/08/2026 |
Anciens postes connus de Geoffrey Lynn
| Sociétés | Poste | Fin |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS ADR | Directeur Technique/Scientifique/R&D | 05/09/2025 |
Avidea Technologies, Inc.
 Avidea Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops T cell immunotherapies for treating cancer, infections and autoimmune diseases | Directeur Général | - |
Formation de Geoffrey Lynn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avidea Technologies, Inc.
Avidea Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops T cell immunotherapies for treating cancer, infections and autoimmune diseases | Commercial Services |
Vaccitech Plc
 Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
